APA (7th ed.) Citation

A, T., S, A., T, S., DL, P., KL, B., C, M., . . . TN, P. (2026). Economic Evaluation of the Addition of Vancomycin to Cefazolin Prophylaxis in Patients Undergoing Arthroplasty. PharmacoEconomics, 44(7), 839. https://doi.org/10.1007/s40273-026-01609-0

Chicago Style (17th ed.) Citation

A, Tran-Duy, et al. "Economic Evaluation of the Addition of Vancomycin to Cefazolin Prophylaxis in Patients Undergoing Arthroplasty." PharmacoEconomics 44, no. 7 (2026): 839. https://doi.org/10.1007/s40273-026-01609-0.

MLA (9th ed.) Citation

A, Tran-Duy, et al. "Economic Evaluation of the Addition of Vancomycin to Cefazolin Prophylaxis in Patients Undergoing Arthroplasty." PharmacoEconomics, vol. 44, no. 7, 2026, p. 839, https://doi.org/10.1007/s40273-026-01609-0.